Revolutionizing Cancer Treatment | BeOne Medicines (beigene.ge) | საიტის ანალიზი

OG სათაური:: Revolutionizing Cancer Treatment | BeOne Medicines
OG აღწერა:: BeOne Medicines, formerly BeiGene, is committed to developing innovative cancer medicines by partnering globally to serve patients everywhere.
კანონიკური:: https://beonemedicines.com/
სქემები:: ვერ მოიძებნა

Living with Cancer: Richard’s Story
Living with Cancer: Geoff and Tina’s story
Building a Breast Cancer Pipeline With Purpose
A Culture That Enables Innovation
BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory…
European Commission Approves TEVIMBRA® as Neoadjuvant/Adjuvant NSCLC Treatment Ahead of Late-Breaking Data…
BeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
BeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million
European Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA® for All Approved…
BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673…
BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Neoadjuvant/Adjuvant NSCLC Treatment
BeOne Medicines to Announce Second Quarter 2025 Financial Results on August 6
European Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment…
BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day
BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA®
BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025

რეგისტრატორი:: proservice ltd
რეგისტრაციის:: 18 February 2021
გასვლის:: 19 February 2026
NS:: ns1.markmonitor.com ns2.markmonitor.com ns3.markmonitor.com ns4.markmonitor.com
დომენის:: BEIGENE.GE
სტატუსი:: Ok